CHRU - Hôpital du Haut Lévêque - Centre François Magendie

Pessac 33604

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Myelodysplastic Syndromes

Studies at this site

• A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment — Running, not enrolling
• Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes — Completed